Cargando…
Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study
SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional s...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950968/ https://www.ncbi.nlm.nih.gov/pubmed/35335042 http://dx.doi.org/10.3390/vaccines10030410 |
_version_ | 1784675270512345088 |
---|---|
author | Al-Qerem, Walid Al Bawab, Abdel Qader Hammad, Alaa Ling, Jonathan Alasmari, Fawaz |
author_facet | Al-Qerem, Walid Al Bawab, Abdel Qader Hammad, Alaa Ling, Jonathan Alasmari, Fawaz |
author_sort | Al-Qerem, Walid |
collection | PubMed |
description | SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional study based on an online questionnaire for Jordanian adults (n = 915) to determine how individuals who have finished the current vaccination regimen feel about a prospective COVID-19 booster shot and what factors might influence their decision. Almost half of the participants (44.6%) intended to get the booster dose of the COVID-19 vaccine. The most frequently mentioned reasons for participants’ reluctance to get the COVID-19 vaccine booster dose were “The benefits of booster dose have not been scientifically proven” (39.8%), followed by “I took the last dose a short time ago, and there will be no need to take the booster dose for at least a year” (24.6%). In turn, “I was infected with COVID-19; thus, I do not require the booster dose” was the least reported reason (13.1%). These findings highlight the considerable hesitancy toward COVID-19 booster immunization among Jordanians, as well as the variables associated with vaccine hesitancy and the most frequently mentioned reasons for hesitancy, which will aid in creating excellent campaigns regarding booster doses. |
format | Online Article Text |
id | pubmed-8950968 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-89509682022-03-26 Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study Al-Qerem, Walid Al Bawab, Abdel Qader Hammad, Alaa Ling, Jonathan Alasmari, Fawaz Vaccines (Basel) Article SARS-CoV-2 (COVID-19) vaccines are critical for containing serious infections. However, as COVID-19 evolves toward more transmissible varieties and serum antibody levels in vaccinated persons steadily decline over time, the likelihood of breakthrough infections increases. This is a cross-sectional study based on an online questionnaire for Jordanian adults (n = 915) to determine how individuals who have finished the current vaccination regimen feel about a prospective COVID-19 booster shot and what factors might influence their decision. Almost half of the participants (44.6%) intended to get the booster dose of the COVID-19 vaccine. The most frequently mentioned reasons for participants’ reluctance to get the COVID-19 vaccine booster dose were “The benefits of booster dose have not been scientifically proven” (39.8%), followed by “I took the last dose a short time ago, and there will be no need to take the booster dose for at least a year” (24.6%). In turn, “I was infected with COVID-19; thus, I do not require the booster dose” was the least reported reason (13.1%). These findings highlight the considerable hesitancy toward COVID-19 booster immunization among Jordanians, as well as the variables associated with vaccine hesitancy and the most frequently mentioned reasons for hesitancy, which will aid in creating excellent campaigns regarding booster doses. MDPI 2022-03-09 /pmc/articles/PMC8950968/ /pubmed/35335042 http://dx.doi.org/10.3390/vaccines10030410 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Al-Qerem, Walid Al Bawab, Abdel Qader Hammad, Alaa Ling, Jonathan Alasmari, Fawaz Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study |
title | Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study |
title_full | Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study |
title_fullStr | Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study |
title_full_unstemmed | Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study |
title_short | Willingness of the Jordanian Population to Receive a COVID-19 Booster Dose: A Cross-Sectional Study |
title_sort | willingness of the jordanian population to receive a covid-19 booster dose: a cross-sectional study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8950968/ https://www.ncbi.nlm.nih.gov/pubmed/35335042 http://dx.doi.org/10.3390/vaccines10030410 |
work_keys_str_mv | AT alqeremwalid willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy AT albawababdelqader willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy AT hammadalaa willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy AT lingjonathan willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy AT alasmarifawaz willingnessofthejordanianpopulationtoreceiveacovid19boosterdoseacrosssectionalstudy |